Thus, we inferred that scutellarin alleviated BLM-induced inflammation via suppressing canonical NLRP3 inflammasome activation, and we for the first time discovered that scutellarin could suppress inflammation in pulmonary fibrosis by inhibiting NLRP3. This evidence concerns the gene NLRP3 and pulmonary fibrosis.